Author

Hyejin Chung

Observed name: H.C. Chung

Institution: ABL Bio (South Korea)

Observed institutions: Yonsei University, ABL Bio (South Korea), Yonsei University Health System

OpenAlex ID: A5110107441

Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

2016 · Yaewon Yang, Okjae Lim, et al. · Cancer Immunology Research · 155

GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo

2013 · Okjae Lim, Yuna Lee, et al. · PLoS ONE · 80

CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation

2023 · Jing Gao, Zhengyi Wang, et al. · Journal for ImmunoTherapy of Cancer · 60

B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8 + tumor-infiltrating lymphocytes

2021 · Gihoon You, Yangsoon Lee, et al. · Science Advances · 57

Abstract 1850: A novel anti-CD137 antibody recognizing the membrane-proximal CD137 domain elicits potent anti-tumor T cell activity in a bispecific antibody format

2021 · Yangsoon Lee, Suyoun Lee, et al. · Cancer Research · 3

124 Randomized Phase Ii Clinical Trial of Intratumoral Injection of Jx-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Hepatocellular Carcinoma

2010 · J. Heo, T. Reid, et al. · Journal of Hepatology · 3

Abstract 6524: A novel HER2/4-1BB bispecific antibody, YH32367 (ABL105) shows potent anti-tumor effect through tumor-directed T cell activation

2020 · Moo Young Song, Eun-Jung Lee, et al. · Cancer Research · 2

Abstract 1139: A novel HER2/4-1BB bispecific antibody, YH32367 (ABL105) exhibits the optimal efficacy and superior safety profile through tumor-directed 4-1BB agonism

2022 · Eunjung Lee, Hyejin Chung, et al. · Cancer Research · 1

The Patterns of Filgrastim Uses in Breast Cancer Patients Receiving Chemotherapy

2003 · Hyejin Chung, WanGyoon Shin, et al. · Korean Journal of Clinical Pharmacy

Works count: 9

Citation count: 361

H-index: 4

I10-index: 4